Topical Finasteride for Postmenopausal Women: A Promising Treatment for Hair Loss

Hair loss is a common concern among postmenopausal women, often caused by female pattern

hair loss, a progressive condition that results in thinning hair and reduced hair density.

A recent study examined the effectiveness of topical finasteride 0.25% in 26 postmenopausal

women over 52 weeks.

The results were encouraging:

-Hair density increased approximately 16%.

- Hair shaft thickness increased approximately 26%.

- No adverse effects were reported in this small study.

Finasteride works by inhibiting the conversion of testosterone to dihydrotestosterone (DHT), a

hormone involved in pattern hair loss.

Unlike oral finasteride, topical treatment is applied directly to the scalp, potentially reducing

systemic exposure.

Importantly, finasteride should not be used during pregnancy and should generally be

avoided in women of childbearing potential.

Combining topical finasteride with other treatments, including minoxidil, platelet-rich

plasma (PRP), or laser therapies, may provide additional improvement in hair growth,

although these combinations were not evaluated in this study.

While these findings are promising, larger controlled studies are needed to establish long-term

safety and effectiveness.

For postmenopausal women experiencing progressive hair thinning, topical finasteride may

offer another treatment option following evaluation by a dermatologist specializing in hair loss.